We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Depressed Heart Patients More Likely to Die

By HospiMedica staff writers
Posted on 22 Aug 2001
A study has found that patients with congestive heart failure (CHF) and with major depression appear twice as likely as those not depressed to die or be re-admitted to the hospital within 12 months. More...
Conducted by researchers at Duke University Medical Center (Durham, NC, USA), the study was published in the August 13, 2001, issue of Archives of Internal Medicine.

The Duke researchers screened consecutive CHF patients admitted during a 15-month period and found that of the 357 screened, 35.3% had some symptoms of depression, with 13.9% diagnosed with major depression. CHF patients who weren't depressed had mortality rates of 5.7% at three months and 13.7% at one year. However, for those with major depression, the death rates jumped to 13% at three months and 16.1% at one year.

As for hospital re-admissions, 36.5% of the nondepressed patients were re-admitted within three months, and 52.3% at one year. For those with major depression, the rates increased to 52.2% at three months, and 80.4% at one year. "If more cardiologists considered the impact of depression on their heart failure patients and treated the depression, the outcomes for these patients might improve,” said Dr. Wei Jiang, author of the study.

The task will be a challenge, Dr. Jiang noted, since most CHF patients take as many as eight different medications per day for their disease, and current anti-depressive medications can interact with them.




Related Links:
Duke Univ.

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Head Rest
Medifa 61114_3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.